MDS Designates Cancer its Major Charitable Cause on World Cancer Day
04 Febbraio 2008 - 2:00PM
PR Newswire (US)
MDS Makes Three-Year Commitment to the International Union Against
Cancer TORONTO, Feb. 4 /PRNewswire-FirstCall/ -- MDS Inc. (TSX:
MDS; NYSE: MDZ), a leading provider of products and services to the
global life sciences markets, declared its increased commitment to
the fight against cancer today designating it as MDS' major
charitable cause. MDS has launched employee awareness and
fundraising events around the world and announced a donation of
nearly $1 million over the next three years to the International
Union Against Cancer (UICC). MDS chose UICC, the world's largest
non-governmental association of cancer-fighting organizations,
because of its global mission to fight the disease. With the
support of partners like MDS, UICC acts as a resource for action
and a voice for change through prevention education programs,
research projects, and other initiatives that can make a real
difference in saving lives and improving the quality of life for
cancer patients and their families throughout the world. "We are
thrilled to support the work of the International Union Against
Cancer," said Stephen P. DeFalco, President and Chief Executive
Officer of MDS Inc. "We have great employees at MDS who are
committed to this fight both as a company and as individuals, not
only on World Cancer Day but every day they come to work." Each
year, more than 11 million new cases of cancer are diagnosed and
more than 7 million people die from cancer. Through its life
sciences businesses, MDS wages a fight against cancer every day: -
MDS has identified oncology as a focus area of clinical research
activity and conducts cancer studies around the world as part of
its full set of contract research services. - MDS partners with
pharma and biotech customers using its isotope technologies to
develop new radiotherapeutics to treat cancers like non-Hodgkin's
lymphoma and primary liver cancer. - MDS produces instruments and
reagents researchers use to understand the disease mechanisms and
develop new drug therapies. About MDS MDS is a global life sciences
company that provides market-leading products and services that our
customers need for the development of drugs and the diagnosis and
treatment of disease. We are a leading global provider of
pharmaceutical contract research, medical isotopes for molecular
imaging, radiotherapeutics, and analytical instruments. MDS has
more than 5,500 highly skilled people in 29 countries. Find out
more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. Source data: International Union Against Cancer
http://www.uicc.org/ DATASOURCE: MDS Inc. CONTACT: Sharon Mathers,
Senior Vice-President, Investor Relations and External
Communications, MDS Inc., (416) 675-6777 x34721,
Copyright